A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal modelsYing Jin, Mark L. Chiu|Frontiers in Oncology|2025Cited by 7